Focus Impact BH3 Acquisition Company
BHAC
$6.00
-$6.00-50.00%
| Weiss Ratings | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D | |||
| Rating Factors | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.31 | |||
| Price History | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -50.00% | |||
| 30-Day Total Return | -42.86% | |||
| 60-Day Total Return | -41.35% | |||
| 90-Day Total Return | -42.36% | |||
| Year to Date Total Return | -41.29% | |||
| 1-Year Total Return | -42.75% | |||
| 2-Year Total Return | -41.80% | |||
| 3-Year Total Return | -39.27% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -56.17% | |||
| 52-Week Low % Change | 198.51% | |||
| Price | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $13.69 | |||
| 52-Week Low Price | $2.01 | |||
| 52-Week Low Price (Date) | Mar 05, 2025 | |||
| 52-Week High Price (Date) | Feb 26, 2025 | |||
| Valuation | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 41.52M | |||
| Enterprise Value | 42.46M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.67 | |||
| Earnings Per Share Growth | 5,514.17% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -5.37 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $6.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -7.64 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.94M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 213 0243 | |||
| Address | 1345 Avenue of the Americas New York, NY 10105 | |||
| Website | www.bh3ac.com | |||
| Country | United States | |||
| Year Founded | 2021 | |||
| Profitability | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -17.77% | |||
| Return on Equity | -- | |||
| Income Statement | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -5.56M | |||
| Net Income (TTM) | -5.27M | |||
| Net Income Avl. to Common (TTM) | -5.27M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 78.42% | |||
| EPS Diluted (TTM) | -0.67 | |||
| EPS Diluted Growth (Q YOY) | 74.56% | |||
| Balance Sheet | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 56.20K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -7.73M | |||
| Current Ratio (Q) | 0.007 | |||
| Book Value Per Share (Q) | -$1.12 | |||
| Total Assets (Q) | 13.76M | |||
| Total Current Liabilities (Q) | 8.10M | |||
| Total Debt (Q) | 959.80K | |||
| Total Liabilities (Q) | 21.48M | |||
| Total Common Equity (Q) | -7.73M | |||
| Cash Flow | BHAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 11.88M | |||
| Cash from Financing (TTM) | -11.27M | |||
| Net Change in Cash (TTM) | -611.70K | |||
| Levered Free Cash Flow (TTM) | 1.25M | |||
| Cash from Operations (TTM) | -1.22M | |||
